Benchmark Capital Advisors lowered its holdings in shares of HCP, Inc. (NYSE:HCP) by 18.3% in the 4th quarter, Holdings Channel reports. The firm owned 23,500 shares of the real estate investment trust’s stock after selling 5,250 shares during the quarter. Benchmark Capital Advisors’ holdings in HCP were worth $613,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Advisory Services Network LLC lifted its holdings in shares of HCP by 4.1% in the 2nd quarter. Advisory Services Network LLC now owns 3,782 shares of the real estate investment trust’s stock worth $121,000 after acquiring an additional 150 shares during the last quarter. Fieldpoint Private Securities LLC bought a new stake in shares of HCP in the 3rd quarter worth about $147,000. Penserra Capital Management LLC bought a new stake in shares of HCP in the 3rd quarter worth about $163,000. Koch Industries Inc. bought a new stake in shares of HCP in the 2nd quarter worth about $208,000. Finally, Cetera Investment Advisers bought a new stake in shares of HCP in the 2nd quarter worth about $208,000. Institutional investors and hedge funds own 90.97% of the company’s stock.

Several equities research analysts have recently issued reports on HCP shares. KeyCorp restated a “hold” rating on shares of HCP in a report on Tuesday, October 17th. BMO Capital Markets restated a “hold” rating and issued a $28.00 target price on shares of HCP in a report on Wednesday, October 18th. Mizuho upgraded shares of HCP from a “neutral” rating to a “buy” rating and set a $32.00 target price for the company in a report on Thursday, November 2nd. Stifel Nicolaus lowered their target price on shares of HCP from $30.00 to $29.00 and set a “hold” rating for the company in a report on Tuesday, November 7th. Finally, Zacks Investment Research upgraded shares of HCP from a “sell” rating to a “hold” rating in a report on Thursday, November 9th. Four equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and four have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $30.14.

Shares of HCP, Inc. (NYSE:HCP) opened at $22.64 on Friday. HCP, Inc. has a twelve month low of $22.63 and a twelve month high of $33.67. The firm has a market cap of $10,620.00, a PE ratio of 40.43, a P/E/G ratio of 4.24 and a beta of 0.22. The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 1.17.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 2nd. Investors of record on Thursday, February 15th will be issued a dividend of $0.37 per share. The ex-dividend date is Wednesday, February 14th. This represents a $1.48 dividend on an annualized basis and a yield of 6.54%. HCP’s payout ratio is 264.29%.

ILLEGAL ACTIVITY NOTICE: “Benchmark Capital Advisors Lowers Holdings in HCP, Inc. (HCP)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2018/02/09/benchmark-capital-advisors-lowers-holdings-in-hcp-inc-hcp.html.

About HCP

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.